$MDCX 8-K SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Other Events On October 23, 2026, Medicus Pharma Ltd. (the "Company") received written notice (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it had regained co...
16 Oct 2026	8-K: Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Medicus Pharma Ltd. (the "Company") effected a 1-for-50 share consolidation (the "Share Consolidation") of the Company's issued and outstanding common shares, no par value (the "Common Shares") by filing Articles of Amendment (the "Artic...
07 Oct 2026	8-K: Other Events Medicus Pharma Ltd. (the "Company") today announced that it will effect a fifty-to-one consolidation (the "Share Consolidation") of the Company's common shares, no par value (the "Common Shares"), to be effective on October 12, 2026. The...
14 Sep 2026	8-K: Termination of a Material Definitive Agreement On September 11, 2026, Medicus Pharma Ltd. (the "Company") and YA II PN, LTD. ("Yorkville") mutually agreed to terminate the Standby Equity Purchase Agreement, dated as of February 10, 2025, between the Company and Yorkville (the "SEPA")...
11 Sep 2026	8-K: Unregistered Sales of Equity Securities NASDAQ Capital Market [Member] \| Common shares, no par value [Member]
03 Sep 2026	8-K: Entry into a Material Definitive Agreement
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
27 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
24 Apr 2026	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule
06 Mar 2026	8-K: Unregistered Sales of Equity Securities
30 Dec 2025	8-K: Entry into a Material Definitive Agreement
08 Dec 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
01 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
14 Nov 2025	8-K: Other Events
17 Oct 2025	8-K: Unregistered Sales of Equity Securities
18 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
12 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation
02 Sep 2025	8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +2 more
22 Aug 2025	8-K: Unregistered Sales of Equity Securities; Other Events
04 Aug 2025	8-K: Other Events

Comments